Home › Chronic Pain › NCT06940986
The PROmoting Pain Self-Management (PROs) Trial: Holistic Pain Care in the Military Health System
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 18 or older * TRICARE Beneficiary * Meets the case definition of chronic MSK pain requiring 2 or more medical encounters within the past year and at least 90 days apart for the same MSK condition indicated by medical encounter data or MSK pain ICD-10 codes in the electronic medical record Exclusion Criteria: * Actively receiving cancer treatment * Currently known to be pregnant * Receiving advanced chronic pain management, including multi-disciplinary or behavioral pain management or mental health or substance use programs (beyond the initial step of the VA/DoD stepped care model for pain management) * Suicidal Ideation determined by a higher than lower risk score on the P4 Screener * Currently undergoing post-surgical rehabilitation
About the study
The goal of this study is to improve pain care in the MHS by identifying effective, whole-person, non-pharmacologic interventions for persons with chronic musculoskeletal pain. The investigators will evaluate two promising, evidence-based holistic health interventions and compare them to usual care.
What is being tested
- Empowered Relief (behavioral)
- Move to Health (behavioral)
- Usual Care as determined by primary care provider (other)
Sponsor: Brooke Army Medical Center · Participants: 608 · Started: Dec 19, 2025
Contact the study team
- Tina Greenlee, PhD · Phone: 210-808-2575
Official record on ClinicalTrials.gov — NCT06940986
Locations in the U.S.
| Alaska | Bassett Army Community Hospital, Fairbanks (Not yet recruiting) |
| Hawaii | Desmond Doss Health Clinic, Schofield Barracks |
| Texas | Brooke Army Medical Center, San Antonio Wilford Hall Ambulatory Surgical Center, San Antonio (Not yet recruiting) |
| Washington | Madigan Army Medical Center, Tacoma (Not yet recruiting) |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.